Navinta
Pre-clinicalNavinta develops and manufactures active pharmaceutical ingredients and intermediates for generic and specialty pharmaceuticals.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $25M
About
Navinta develops and manufactures active pharmaceutical ingredients and intermediates for generic and specialty pharmaceuticals.
Generic Drugs
Funding History
2Total raised:$25M
Series B$15MJun 15, 2009
Series A$10MJun 15, 2007